皮肤微碎片用于治疗糖尿病足:一个案例系列
José Luis Lázaro-Martínez1, Marta García-Madrid1, Mateo López-Moral1
1Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
The international journal of lower extremity wounds
|January 8, 2025
概括
皮肤微碎片疗法在糖尿病足 (DFU) 中表现有前途. 在一系列病例中,60%的患者在12周内实现了完整的伤口关闭,这表明了安全有效的治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 再生医学是一种再生医学.
- 足部医学是一门专业.
背景情况:
- 糖尿病足 (DFU) 在伤口护理方面是一个重大挑战.
- 慢性DFU往往表现出不良的愈合结果,需要新的治疗方法.
研究的目的:
- 评估使用hy-tissue微移植 (HT-MG) 的皮肤微碎片疗法的临床疗效,用于管理难以愈合的糖尿病足.
- 评估伤口愈合率,上皮化时间和伤口面积缩小.
主要方法:
- 一个涉及10名慢性DFU患者的前性病例系列.
- 治疗涉及到hy-组织微移植 (HT-MG) 的应用.
- 评估的结果包括完整的伤口关闭,愈合时间,伤口面积减少 (WAR) 和12周的不良事件.
主要成果:
- 60%的患者在12周内实现了完整的伤口关闭.
- 平均愈合时间为7.8周.
- 平均WAR在4周时为67.2%,在12周时为87.5%.
- 该程序被很好地容忍,没有报告的并发症或不良事件.
结论:
- 卫生组织微移植 (HT-MG) 似乎是慢性糖尿病足的安全有效治疗方法.
- 这种疗法促进了明显的伤口愈合,并缩短了愈合时间.
- 需要进一步的研究来证实这些发现并评估长期结果.
相关概念视频
Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Hypoglycemia
30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Diabetic Foot Ulcer
33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


